Ainos (NASDAQ:AIMDW) Shares Up 29.7% – Should You Buy?

Ainos, Inc. (NASDAQ:AIMDWGet Free Report)’s share price shot up 29.7% on Wednesday . The company traded as high as $0.24 and last traded at $0.24. 1,011 shares changed hands during mid-day trading, a decline of 92% from the average session volume of 12,273 shares. The stock had previously closed at $0.19.

Ainos Stock Up 29.7%

The business’s fifty day moving average price is $0.25 and its two-hundred day moving average price is $0.17.

About Ainos

(Get Free Report)

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.

Featured Stories

Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.